Every clinical trial moves through a series of controlled activities. Each stage adds data, decisions, documentation, and operational responsibility that directly affect participant safety, protocol compliance, and data integrity. Unfortunately, completed study activity alone does not confirm compliant execution. Every critical step requires confirmation of correct execution, clear documentation, proper review, and controlled oversight. Clinical

Notably, a protocol deviation refers to any departure from the approved study protocol, whether planned or unplanned. It may involve missed procedures, incorrect dosing, out-of-window visits, or incomplete documentation. Each deviation must be assessed for its impact on participant safety and data integrity, in line with GCP expectations. In practice, most deviations do not originate

Clinical trials operate across two distinct responsibilities. CTMS supports study execution through participant management, scheduling, and site coordination. QMS supports quality and compliance through document control, training management, deviation tracking, and CAPA. Each system addresses a specific need within clinical trial data management. Clinical research teams often assume that a traditional Clinical Trial Management System

  The World Health Organization defines pharmacovigilance as the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other medicine-related problem. Notably, Pharmacovigilance scope requires structured processes, controlled documentation, and continuous oversight, which directly aligns with quality management systems.  It is essential to understand how pharmacovigilance operates within